v3.26.1
Condensed Consolidated Statements of Redeemable Convertible Noncontrolling Interests and Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Total BridgeBio Stockholders’ Deficit
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non- controlling Interests
Temporary equity, beginning balance at Dec. 31, 2024 [1] $ 142              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of noncontrolling interests 800              
Transfers from (to) noncontrolling interests 379              
Net loss (1,548)              
Temporary equity, ending balance at Mar. 31, 2025 (227)              
Beginning balance (in shares) at Dec. 31, 2024 [1]     190,044,473          
Beginning balance at Dec. 31, 2024 [1] (1,457,754) $ (1,467,904) $ 196 $ (275,000) $ 1,903,155 $ 8 $ (3,096,263) $ 10,150
Beginning balance (in shares) at Dec. 31, 2024 [1]       6,191,761        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)     (1,405,411) (1,405,411)        
Repurchase of common stock (48,276) (48,276)   $ (48,276)        
Issuance of shares under equity compensation plans (in shares)     1,081,744          
Issuance of shares under equity compensation plans 2,521 2,521 $ 1   2,520      
Issuance of common stock under employee stock purchase plan ESPP (in shares)     156,097          
Issuance of common stock under employee stock purchase plan (ESPP) 3,237 3,237     3,237      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)     (50,880)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (1,776) (1,776)     (1,776)      
Stock-based compensation 32,057 32,057     32,057      
Transfers from (to) noncontrolling interests (379) (824)     (824)     445
Unrealized loss on available-for-sale securities (8) (8)       (8)    
Net loss (168,060) (167,422)         (167,422) (638)
Ending balance (in shares) at Mar. 31, 2025     189,826,023          
Ending balance at Mar. 31, 2025 (1,638,438) (1,648,395) $ 197 $ (323,276) 1,938,369 0 (3,263,685) 9,957
Ending balance (in shares) at Mar. 31, 2025       7,597,172        
Temporary equity, beginning balance at Dec. 31, 2024 [1] 142              
Temporary equity, ending balance at Jun. 30, 2025 (445)              
Beginning balance (in shares) at Dec. 31, 2024 [1]     190,044,473          
Beginning balance at Dec. 31, 2024 [1] (1,457,754) (1,467,904) $ 196 $ (275,000) 1,903,155 8 (3,096,263) 10,150
Beginning balance (in shares) at Dec. 31, 2024 [1]       6,191,761        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized loss on available-for-sale securities (7)              
Ending balance (in shares) at Jun. 30, 2025     191,162,659          
Ending balance at Jun. 30, 2025 (1,777,974) (1,787,860) $ 198 $ (323,276) 1,980,805 1 (3,445,588) 9,886
Ending balance (in shares) at Jun. 30, 2025       7,597,172        
Temporary equity, beginning balance at Mar. 31, 2025 (227)              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of noncontrolling interests 750              
Transfers from (to) noncontrolling interests 400              
Net loss (1,368)              
Temporary equity, ending balance at Jun. 30, 2025 (445)              
Beginning balance (in shares) at Mar. 31, 2025     189,826,023          
Beginning balance at Mar. 31, 2025 (1,638,438) (1,648,395) $ 197 $ (323,276) 1,938,369 0 (3,263,685) 9,957
Beginning balance (in shares) at Mar. 31, 2025       7,597,172        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under equity compensation plans (in shares)     1,395,587          
Issuance of shares under equity compensation plans 7,159 7,159 $ 1   7,158      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)     (58,951)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (1,995) (1,995)     (1,995)      
Stock-based compensation 38,089 38,089     38,089      
Transfers from (to) noncontrolling interests (400) (816)     (816)     416
Unrealized loss on available-for-sale securities 1 1       1    
Net loss (182,390) (181,903)         (181,903) (487)
Ending balance (in shares) at Jun. 30, 2025     191,162,659          
Ending balance at Jun. 30, 2025 (1,777,974) (1,787,860) $ 198 $ (323,276) 1,980,805 1 (3,445,588) 9,886
Ending balance (in shares) at Jun. 30, 2025       7,597,172        
Temporary equity, beginning balance at Dec. 31, 2025 [2] (570)              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Transfers from (to) noncontrolling interests 1,489              
Net loss (1,870)              
Temporary equity, ending balance at Mar. 31, 2026 $ (951)              
Beginning balance (in shares) at Dec. 31, 2025 194,771,957   194,771,957 [2]          
Beginning balance at Dec. 31, 2025 [2] $ (2,076,011) [3] (2,086,610) $ 202 $ (323,276) 2,057,646 12 (3,821,194) 10,599
Beginning balance (in shares) at Dec. 31, 2025 7,597,172     7,597,172 [2]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)     (1,081,825) (1,081,825)        
Repurchase of common stock $ (82,500) (82,500)   $ (82,500)        
Issuance of shares under equity compensation plans (in shares)     1,940,523          
Issuance of shares under equity compensation plans 22,589 22,589 $ 2   22,587      
Issuance of common stock under employee stock purchase plan ESPP (in shares)     131,185          
Issuance of common stock under employee stock purchase plan (ESPP) 5,466 5,466     5,466      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)     (54,138)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (4,074) (4,074)     (4,074)      
Stock-based compensation 32,784 32,784     32,784      
Issuance of noncontrolling interests 16             16
Transfers from (to) noncontrolling interests (1,489) (1,955)     (1,955)     466
Unrealized loss on available-for-sale securities (20) (20)       (20)    
Net loss (164,685) (164,043)         (164,043) (642)
Ending balance (in shares) at Mar. 31, 2026     195,707,702          
Ending balance at Mar. 31, 2026 (2,267,924) (2,278,363) $ 204 $ (405,776) 2,112,454 (8) (3,985,237) 10,439
Ending balance (in shares) at Mar. 31, 2026       8,678,997        
Temporary equity, beginning balance at Dec. 31, 2025 [2] (570)              
Temporary equity, ending balance at Jun. 30, 2026 $ (1,018)              
Beginning balance (in shares) at Dec. 31, 2025 194,771,957   194,771,957 [2]          
Beginning balance at Dec. 31, 2025 [2] $ (2,076,011) [3] (2,086,610) $ 202 $ (323,276) 2,057,646 12 (3,821,194) 10,599
Beginning balance (in shares) at Dec. 31, 2025 7,597,172     7,597,172 [2]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized loss on available-for-sale securities $ (19)              
Ending balance (in shares) at Jun. 30, 2026 195,284,352   195,284,352          
Ending balance at Jun. 30, 2026 $ (2,504,875) (2,515,215) $ 206 $ (533,279) 2,155,318 (7) (4,137,453) 10,340
Ending balance (in shares) at Jun. 30, 2026 10,582,998     10,582,998        
Temporary equity, beginning balance at Mar. 31, 2026 $ (951)              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Transfers from (to) noncontrolling interests 2,682              
Net loss (2,749)              
Temporary equity, ending balance at Jun. 30, 2026 (1,018)              
Beginning balance (in shares) at Mar. 31, 2026     195,707,702          
Beginning balance at Mar. 31, 2026 (2,267,924) (2,278,363) $ 204 $ (405,776) 2,112,454 (8) (3,985,237) 10,439
Beginning balance (in shares) at Mar. 31, 2026       8,678,997        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)     (1,904,001) (1,904,001)        
Repurchase of common stock (127,503) (127,503)   $ (127,503)        
Issuance of shares under equity compensation plans (in shares)     1,545,170          
Issuance of shares under equity compensation plans 5,223 5,223 $ 2   5,221      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)     (64,519)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (4,267) (4,267)     (4,267)      
Stock-based compensation 45,419 45,419     45,419      
Transfers from (to) noncontrolling interests (2,682) (3,509)     (3,509)     827
Unrealized loss on available-for-sale securities 1 1       1    
Net loss $ (153,142) (152,216)         (152,216) (926)
Ending balance (in shares) at Jun. 30, 2026 195,284,352   195,284,352          
Ending balance at Jun. 30, 2026 $ (2,504,875) $ (2,515,215) $ 206 $ (533,279) $ 2,155,318 $ (7) $ (4,137,453) $ 10,340
Ending balance (in shares) at Jun. 30, 2026 10,582,998     10,582,998        
[1] The consolidated balances as of December 31, 2025 and 2024 are derived from the audited consolidated financial statements as of those dates.
[2] The consolidated balances as of December 31, 2025 and 2024 are derived from the audited consolidated financial statements as of those dates.
[3] The condensed consolidated balance sheet as of December 31, 2025 is derived from the audited consolidated financial statements as of that date.